socalTECH

APRIL 29, 2021

Thousand Oaks-based Capsida Biotherapeutics, a new biotechnology company focused on using adeno-associated virus (AAV) engineering and cargo development platform to develop tissue-targeted gene therapies for multiple types of diseases, has uncloaked from stealth mode, saying it has raised $140M in total capital.

Westlake Village 113

Westlake Village Thousand Oaks Funding CalTech 113

socalTECH

MARCH 8, 2016

Thousand Oaks-based Amgen has made another investment this morning in immunology startup Tizona Therapeutics , via its venture capital arm, Amgen Ventures. Series A investors--including Amgen Ventures--also participated, with investments from MPM Capital, Astellas Venture Management and InterWest Partners.

Thousand Oaks 100

Thousand Oaks Funding Venture Capital Invest 100

socalTECH

DECEMBER 17, 2013

Thousand Oaks-based biopharmaceuticals startup Atara Biotherapeutics announced this morning that it has raised $38.5M in a Series B funding round, for its efforts to develop treatments for patients with end-stage renal disease. atara biotherapeutics venture capital renal disease lifescience amgen'

Thousand Oaks 180

Thousand Oaks Venture Capital Capital Funding 180

socalTECH

NOVEMBER 7, 2013

Thousand Oaks-based ImmunGene , a startup biotech company developing antibody-based, protein therapeutics for treating cancer, said today that it has raised $9M in a Series A funding, to advance its early stage development products. According to the company, the funding came from Ally Bridge Group. READ MORE>>.

Thousand Oaks 164

Thousand Oaks UCLA Venture Capital Equity 164

socalTECH

OCTOBER 9, 2015

Thousand Oaks-based Amgen has seen an exit out of its startup investment portfolio, and activities of its Amgen Ventures venture capital arm, at Berkeley-based Adheron Therapeutics this morning. READ MORE>>.

Thousand Oaks 100

Thousand Oaks Venture Capital Activity Capital 100

socalTECH

FEBRUARY 21, 2013

Xirrus , the wireless hardware provider based in Thousand Oaks, has just raised $10.1M in a funding round, part of an ongoing $11.0M funding, according to a regulatory filing by the company. Details on the funding have not yet been announced by the company.

Thousand Oaks 164

Thousand Oaks Conference Networking Capital 164